Medpace Holdings IPO Info
Company Name: Medpace Holdings
Stock Symbol: MEDP
Exchange: NASDAQ
Status: Priced
IPO Date: 8/11/2016
IPO Price:
23.00 (
56.83%)
Underwriters
Jefferies LLC and Credit Suisse
Amount of Offering: N/A
Number of Shares Offered: 7 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,300 people across 35 countries.
News Headlines
